---
license: cc-by-nc-nd-4.0
task_categories:
  - image-classification
modality:
  - image
language:
  - en
tags:
  - medical
  - ophthalmology
  - fairness
  - glaucoma
  - AMD
  - diabetic-retinopathy
  - OCT
  - fundus
pretty_name: Harvard-FairVision
size_categories:
  - 10K<n<100K
configs:
  - config_name: glaucoma
    data_files:
      - path: Glaucoma/ReadMe/data_summary_glaucoma.csv
        split: train
  - config_name: dr
    data_files:
      - path: DR/ReadMe/data_summary_dr.csv
        split: train
  - config_name: amd
    data_files:
      - path: AMD/ReadMe/data_summary_amd.csv
        split: train
---

# Dataset Card: Harvard-FairVision

## Dataset Summary

Harvard-FairVision is the **first large-scale medical fairness dataset with both 2D and 3D imaging data**, covering three major eye diseases affecting approximately 380 million people worldwide. It contains 30,000 subjects (10,000 per disease) across Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR), and glaucoma, each with paired SLO fundus photos and 3D OCT B-scans and six demographic identity attributes.

This dataset was introduced in the paper: [FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling](https://arxiv.org/pdf/2310.02492).

## Dataset Details

### Dataset Description

| Field           | Value |
|-----------------|-------|
| **Institution** | Department of Ophthalmology, Harvard Medical School |
| **Tasks**       | AMD detection, diabetic retinopathy detection, glaucoma detection |
| **Modalities**  | Scanning Laser Ophthalmoscopy (SLO) fundus images, 3D OCT B-scans |
| **Scale**       | 30,000 subjects (10,000 per disease) |
| **OCT size**    | 200 × 200 × 200 (glaucoma), 128 × 200 × 200 (AMD, DR) |
| **SLO size**    | 512 × 664 (folders), 200 × 200 (NPZ, normalized to [0, 255]) |
| **Total size**  | ~600 GB |
| **License**     | [CC BY-NC-ND 4.0](https://creativecommons.org/licenses/by-nc-nd/4.0/) |

- **Curated by:** Yan Luo, Muhammad Osama Khan, Yu Tian, Min Shi, Zehao Dou, Tobias Elze, Yi Fang, Mengyu Wang
- **License:** [CC BY-NC-ND 4.0](https://creativecommons.org/licenses/by-nc-nd/4.0/) — non-commercial research only
- **Paper:** [arXiv:2310.02492](https://arxiv.org/abs/2310.02492)
- **Contact:** harvardophai@gmail.com, harvardairobotics@gmail.com

### Dataset Structure

```
FairVision
├── AMD
│   ├── Training
│   ├── Validation
│   └── Test
├── data_summary_amd.csv
├── DR
│   ├── Training
│   ├── Validation
│   └── Test
├── data_summary_dr.csv
├── Glaucoma
│   ├── Training
│   ├── Validation
│   └── Test
└── data_summary_glaucoma.csv
```

Each split folder contains SLO fundus photos (`slo_xxxxx.jpg`) and NPZ files (`data_xxxxx.npz`). Per-disease metadata CSVs (`data_summary_*.csv`) provide race, gender, ethnicity, marital status, age, and preferred language for all subjects.

### Data Fields

All NPZ files share the following demographic and imaging fields:

| Field           | Description |
|-----------------|-------------|
| `slo_fundus`    | SLO fundus image, 200 × 200 (normalized) |
| `oct_bscans`    | 3D OCT B-scans (200 × 200 × 200 for glaucoma; 128 × 200 × 200 for AMD/DR) |
| `race`          | `0` = Asian, `1` = Black, `2` = White |
| `male`          | `0` = Female, `1` = Male |
| `hispanic`      | `0` = Non-Hispanic, `1` = Hispanic |
| `maritalstatus` | `0` = Married, `1` = Single, `2` = Divorced, `3` = Widowed, `4` = Legally Separated |
| `language`      | `0` = English, `1` = Spanish, `2` = Other |

Disease-specific label fields:

| Disease   | Field           | Values |
|-----------|-----------------|--------|
| Glaucoma  | `glaucoma`      | `0` = non-glaucoma, `1` = glaucoma |
| AMD       | `amd_condition` | 9-class condition string, mapped to `0` = no AMD, `1` = early dry, `2` = intermediate dry, `3` = advanced |
| DR        | `dr_subtype`    | 6-class condition string, mapped to `0` = non-vision-threatening, `1` = vision-threatening (severe NPDR or PDR) |

## Uses

### Direct Use

- Fairness benchmarking for 2D and 3D ophthalmic disease classification across race, gender, and ethnicity
- Multi-disease fairness analysis (AMD, DR, glaucoma) under a unified framework
- Development and evaluation of fairness learning methods for medical imaging
- Comparative study of 2D vs. 3D model fairness in clinical AI

### Out-of-Scope Use

Clinical decisions, patient care, or any commercial application. This dataset shall not be used for clinical decisions at any time.

## Access

The "Harvard" designation indicates the dataset originates from the Department of Ophthalmology at Harvard Medical School. It does not imply endorsement, sponsorship, or legal responsibility by Harvard University or Harvard Medical School.

## Citation

**BibTeX:**

```bibtex
@misc{luo2024fairvisionequitabledeeplearning,
  title={FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling},
  author={Yan Luo and Muhammad Osama Khan and Yu Tian and Min Shi and Zehao Dou and Tobias Elze and Yi Fang and Mengyu Wang},
  year={2024},
  eprint={2310.02492},
  archivePrefix={arXiv},
  primaryClass={cs.CV},
  url={https://arxiv.org/abs/2310.02492}
}
```

**APA:**

Luo, Y., Khan, M. O., Tian, Y., Shi, M., Dou, Z., Elze, T., Fang, Y., & Wang, M. (2024). FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling. *arXiv preprint arXiv:2310.02492*.